Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report.
about
Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Determining priority signs and ...... gnant gliomas: Panel 1 Report.
@en
type
label
Determining priority signs and ...... gnant gliomas: Panel 1 Report.
@en
prefLabel
Determining priority signs and ...... gnant gliomas: Panel 1 Report.
@en
P2093
P2860
P356
P1433
P1476
Determining priority signs and ...... ignant gliomas: Panel 1 Report
@en
P2093
Allison M Bishof
Christina Theodore-Oklota
Martin J B Taphoorn
Martin Klein
Paul D Brown
P2860
P304
P356
10.1093/NEUONC/NOV267
P478
18 Suppl 2
P577
2016-03-01T00:00:00Z